Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: An analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998

By Bacci Gaetano   Longhi Alessandra   Ferrari Stefano   Mercuri Mario   Versari Michela   Bertoni Franco  

Acta Oncologica, Vol. 45, Iss. 4, 2006-06 ,pp. : 469-475

Informa Healthcare

Access to resources Recommend Favorite

Retrospective evaluation of combined modality treatment and prognostic factors in patients with esophageal cancer

By Neuhof Dirk   Neumayer Florian   Einbeck Wolfgang   Haschemian Kai   Mai Sabine   Hochhaus Andreas   Willeke Frank   Rudi Jochen   Debus Jürgen   Wenz Frederik  

Acta Oncologica, Vol. 44, Iss. 2, 2005-03 ,pp. : 168-173

Informa Healthcare

Access to resources Recommend Favorite

Validation of a clinical prognostic model in Chinese patients with metastatic and advanced pretreated non-small cell lung cancer treated with gefitinib

By Wang Fenghua  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 331-335

Humana Press, Inc

Access to resources Recommend Favorite

Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer

By Yanagihara Kazuhiro   Yoshimura Kenichi   Niimi Miyuki   Yasuda Hiroyasu   Sasaki Takahiko   Nishimura Takafumi   Ishiguro Hiroshi   Matsumoto Shigemi   Kitano Toshiyuki   Kanai Masashi   Misawa Akiko   Tada Harue   Teramukai Satoshi   Mio Tadashi   Fukushima Masanori  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 5, 2010-10 ,pp. : 913-918

Springer Publishing Company

Access to resources Recommend Favorite

Lower lobe origin is a poor prognostic factor in locally advanced non-small-cell lung cancer patients treated with induction chemoradiotherapy

By                    

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 706-712

Science Publishers

Access to resources Recommend Favorite